← All diseases Cancer

Multiple myeloma

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (64)Meta-analysis (11)Treatment guideline (2)Systematic review (24)Randomized trial (16)Phase 3 study (11)Clinical trial (628)Review article (259)Early study (phase 1 or 2) (44)Case report (253)Laboratory or animal study (23)Commentary or editorial (45)Retracted Publication (4)Concerns have been raised (1) Studies currently recruiting participants only (46)

Filter

Publications (1566)

• Downregulation of miRNA-15a and miRNA-16 promote tumor proliferation in multiple myeloma by increasing CABIN1 expression. (2018/01/01) ♡
• Transfusion management for patients taking an anti-CD38 monoclonal antibody. (2018/01/01) ♡
• Multiple myeloma and central nervous system involvement: experience of a Brazilian center. (2018/01/01) ♡
• Can dentists detect multiple myeloma through oral manifestations? (2018/01/01) ♡
• Platelet Count before Peripheral Blood Stem Cell Mobilization Is Associated with the Need for Plerixafor But Not with the Collection Result. (2018/01/01) ♡
• Rationale and Design of the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. (2018/01/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4). (2018/01/01) ♡
• Precision Medicine for Relapsed Multiple Myeloma on the Basis of an Integrative Multiomics Approach. (2018/01/01) ♡
• Correction to: A Rapid and Robust Protocol for Reduced Representation Bisulfite Sequencing in Multiple Myeloma. (2018/01/01) ♡
• [Indicators of kidney damage in patients with multiple myeloma in the process of chemotherapeutic treatment.]. (2018/01/01) ♡
• Association of ABCB1 T-129C polymorphism and multiple myeloma risk in Polish population. (2018/01/01) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma. (2017/12/27) ♡
• CRISPR knock out of programmed cell death protein 1 enhances anti-tumor activity of cytotoxic T lymphocytes. (2017/12/27) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Targeting CD38 alleviates tumor-induced immunosuppression. (2017/12/26) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Multiple Myeloma: The Case of the Disappearing Band. (2017/12/22) ♡
• PRDI-BF1 and PRDI-BF1P isoform expressions correlate with disease status in multiple myeloma patients. (2017/12/22) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Metastatic prostate cancer with bone marrow infiltration mimicking multiple myeloma. (2017/12/22) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Prostate carcinoma presenting with diffuse osteolytic metastases and supraclavicular lymphadenopathy mimicking multiple myeloma. (2017/12/19) ♡
• Monoclonal gammopathy of renal significance (MGRS) increases the risk for progression to multiple myeloma: an observational study of 2935 MGUS patients. (2017/12/18) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Human DKK1 and human HSP70 fusion DNA vaccine induces an effective anti-tumor efficacy in murine multiple myeloma. (2017/12/17) ♡
• Pomalidomide-induced hypothyroidism. (2017/12/15) ♡
• [Effects of PSMB5 on proliferation and bortezomib chemo-resistance in human myeloma cells and its related molecular mechanisms]. (2017/12/14) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Allograft for Myeloma: Examining Pieces of the Jigsaw Puzzle. (2017/12/11) ♡
• Truncated protein tyrosine phosphatase receptor type O suppresses AKT signaling through IQ motif containing GTPase activating protein 1 and confers sensitivity to bortezomib in multiple myeloma. (2017/12/07) ♡
• Effective impairment of myeloma cells and their progenitors by hyperthermia. (2017/12/07) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Optimizing therapy for del(17p) multiple myeloma. (2017/12/06) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure. (2017/12/06) ♡
• YM155 exerts potent cytotoxic activity against quiescent (G(0)/G(1)) multiple myeloma and bortezomib resistant cells via inhibition of survivin and Mcl-1. (2017/12/04) ♡
• Role of IRF4 in resistance to immunomodulatory (IMid) compounds(®) in Waldenström's macroglobulinemia. (2017/12/04) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The therapeutic effect of modified Huangqi Guizhi Wuwu Tang for multiple myeloma: An 18-year follow-up case report. (2017/12/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction. (2017/12/01) ♡
• Characteristics of Vitamin B12 Deficiency in Patients With Plasma Cell Disorders. (2017/12/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research analysis. (2017/12/01) ♡
• Anaesthesia for fixation of repeated pathological fractures in a patient with multiple myeloma. (2017/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Multiple myeloma masquerading as panuveitis in a middle-aged woman. (2017/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Multiple myeloma presenting with acquired cutis laxa and primary systemic amyloidosis. (2017/12/01) ♡
• Incorporating monoclonal antibodies into the management of multiple myeloma. (2017/12/01) ♡
• Monitoring multiple myeloma. (2017/12/01) ♡
• STAT3 expression is associated with poor survival in non-elderly adult patients with newly diagnosed multiple myeloma. (2017/12/01) ♡
• Bortezomib overcomes the negative prognostic impact of renal impairment in a newly diagnosed elderly patient with multiple myeloma: A case report. (2017/12/01) ♡
• Proteasome and heat shock protein 70 (HSP70) inhibitors as therapeutic alternative in multiple myeloma. (2017/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A rare case report of multiple myeloma presenting with paralytic ileus and type II respiratory failure due to hypercalcemic crisis. (2017/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Longitudinal extensive transverse myelitis with an abnormal uFLC ratio in a pediatric patient: Case report and literature review. (2017/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Treatment-related acute granulocyte-monocytic leukemia from multiple myeloma: A case report and literature review. (2017/12/01) ♡
• Recombinant human thrombopoietin improves the efficacy of intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor in mobilizing peripheral blood stem cells in patients with multiple myeloma: A cohort study. (2017/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Asymptomatic solitary bladder plasmocytoma: A case report and literature review. (2017/12/01) ♡
• Percutaneous kyphoplasty versus posterior spinal fixation with vertebroplasty for treatment of Kümmell disease: A case-control study with minimal 2-year follow-up. (2017/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Proteasome inhibitors: structure and function. (2017/12/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Proteasome inhibitor-based therapy for treatment of newly diagnosed multiple myeloma. (2017/12/01) ♡
• Interview with Dr Philip McCarthy. (2017/12/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.